Company news
Bide Pharmatech Co. Ltd. news in 2025
Bide Pharmatech Co. Ltd.'s news releases, calls and decks from 2025, newest first.
Indicative Announcement on Change in Shareholder's Equity Reaching an Integer Multiple of 5%
December 22, 2025
Announcement on Resolutions of the 5th Extraordinary General Meeting in 2025
December 10, 2025
Announcement on the By-election of Non-independent Directors
November 24, 2025
Announcement on Convening the Q3 2025 Performance Briefing
November 19, 2025
Indicative Announcement on Shareholder's Equity Change Reaching 1%
November 14, 2025
Report for Q3 2025
October 29, 2025
Announcement on Planning to Conduct Foreign Exchange Hedging Business
October 15, 2025
Announcement on Correction of 2025 Semi-annual Report
September 12, 2025
Announcement on Completing Industrial and Commercial Change and Obtaining Business Licenses
September 2, 2025
Announcement on Making Provisions for Asset Impairment for the Half-Year Period of 2025
August 21, 2025
Announcement on Resignation of Director and Election of Employee Director
August 15, 2025
Announcement on Resolutions of the 4th Extraordinary General Meeting in 2025
July 31, 2025
Notice on Convening the 4th Extraordinary General Meeting in 2025
July 15, 2025
Announcement on Adjusting Upper Limit of Repurchase Price after Implementation of Dividend Distribution for 2024
July 2, 2025
Announcement on Progress in Repurchasing Shares
June 4, 2025
Announcement on Implementation of Dividend Distribution for 2024
June 2, 2025
Announcement on Appointment of Secretary of the Board of Directors
May 19, 2025
Announcement on Shares Repurchased through Call Auction Reaching 2% of the Company's Share Capital and Repurchase Progress
May 16, 2025
Announcement on Resolution of the 2024 Annual General Meeting
May 14, 2025
Announcement on Resolutions of the 21st Meeting of the 2nd Board of Directors
April 23, 2025
Announcement on Resolution of the 20th Meeting of the 2nd Board of Directors
April 18, 2025
Announcement on Convening an Investor Briefing regarding the Termination of the Issuance of Shares for Asset Acquisition and the Raising of Supporting Funds
April 16, 2025
Announcement on Resolution of the 19th Meeting of the 2nd Board of Directors
April 14, 2025
Announcement on Repurchasing 1% of the Company's Share Capital through Call Auction and Repurchase Progress
April 7, 2025
Announcement on Progress in Planning Major Asset Restructuring and Risk Warning
March 28, 2025
Announcement on Appointment of Chief Financial Officer
March 24, 2025
Announcement on the Resignation of Directors, Secretary of the Board and Chief Financial Officer
March 11, 2025
Announcement on Initially Repurchasing Shares through Call Auction
March 6, 2025
Announcement on Progress in Planning Major Asset Restructuring
February 27, 2025
Announcement on Preliminary Earnings Estimate for 2024
February 25, 2025
Announcement on Resolution of the 3rd Extraordinary General Meeting in 2025
February 24, 2025
Announcement on Shareholdings of Top 10 Shareholders and Top 10 Shareholders without Sales Restrictions Concerning Shares Repurchase
February 21, 2025
Announcement on Resolution of the 17th Meeting of the 2nd Board of Directors
February 7, 2025